Company profile
Health Sciences Group, Inc.
OTC: HESG · Healthcare · Biotechnology
#955 of 1,418 Healthcare companies by revenuetop-decile growth
EA Score
——FH —DQ —GM —SS 40
v0.1 · 5/100 weight · pillars only
↑ revenue growth (YoY), listing tenure · ↓ workforce scale, growth stability
Methodology →Revenue TTM
$69.3k
Rev growth YoY (TTM)
-101.6%
Net income (FY)
-$54.5k
Employees
2
as of 2026-08-25
Market cap
$1.9M
as of 2026-08-25
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$358.4k$358.4k2012
Net income-$54.5k-$54.5k2012
Operating income-$54.5k-$54.5k2012
Total assets$1.0M$1.0M2012
Liabilities$435.7k$435.7k2012
Equity$595.9k$595.9k2012
Revenue trend
FY2000 – FY2012 · USD
FY00
FY01
FY02
FY03
FY04
FY05
FY12
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Health Sciences Group, Inc.’s revenue?
Health Sciences Group, Inc. booked $358.4k in FY2012 revenue, growing 496% year over year — faster than 94% of Healthcare companies we track, at a -15.2% net margin.
Peers · Healthcare
America Great Health39DOMNI Health, Inc.——BioRestorative Therapies, Inc.38DUltimate Sports, Inc.——Core One Labs Inc.——Pulse Biosciences, Inc.43DNeighbors
Orange →Key facts
CEOThomas Gaffney
SectorHealthcare
IndustryBiotechnology
HeadquartersNewport Beach, CA
ExchangeOTC: HESG
Employees2
IPO date2001-08-06
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.